Does the informal caregiver notice HIV associated mild cognitive impairment in people living with HIV?

References

• Ama, N. O. (2011). Experiences and perceptions of people living with HIV and AIDS under the community home-based care programme in Botswana. The Journal of Family Welfare, 57, 134–144.
   Google Scholar
• Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., … Clifford, D. B. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18), 1789–1799. doi: 10.1212/01.WNL.0000287431.88658.8b
   PubMed Web of Science ®Google Scholar
• Collins, L. G., & Swartz, K. (2011). Caregiver care. American Family Physician, 83(11), 1309–1317.
   PubMed Web of Science ®Google Scholar
• Cysique, L. A., Bain, M. P., Brew, B. J., & Murray, J. M. (2011). The burden of HIV associated neurocognitive impairment in Australia and its estimates for the future. Sexual Health, 8, 541–550. doi: 10.1071/SH11003
   PubMed Web of Science ®Google Scholar
• Cysique, l., Maruff, P., Darby, D., & Brew, B. (2006). The assessment of cognitive function in advanced HIV-1 infection and AIDS Dementia complex using a new computerised cognitive test battery. Archives of Clinical Neuropsychology, 21, 185–194. doi: 10.1016/j.acn.2005.07.011
   PubMed Web of Science ®Google Scholar
• Cysique, L. A., Vaida, F., Letendre, S., Gibson, S., Cherner, M., Woods, S. P., … McCutchan, J. A. (2009). Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology, 73(5), 342–348. doi: 10.1212/WNL.0b013e3181ab2b3b
   PubMed Web of Science ®Google Scholar
• De Ronchi, D., Faranca, I., Berardi, D., Scudellari, P., Borderi, M., Manfredi, R., & Fratiglioni, L. (2002). Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors. Archives of Neurology, 59(5), 812–818. doi: 10.1001/archneur.59.5.812
   PubMed Web of Science ®Google Scholar
• Fabiani, S., Pinto, B., & Bruschi, F. (2013). Toxoplasmosis and neuropsychiatric diseases: Can serological studies establish a clear relationship? Neurological Sciences, 34(4), 417–425. doi:10.1007/s10072-012-1197-4
   PubMed Web of Science ®Google Scholar
• Fiala, M., Eshleman, A. J., Cashman, J., Lin, J., Lossinsky, A. S., Suarez, V., … Yang, W. (2005). Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells. Journal of Neurovirology, 11, 281–291. doi:10.1080/13550280590952835
   PubMed Web of Science ®Google Scholar
• Gallant, J. (2000). Strategies for long-term success in the treatment of HIV infection. Journal of America Medical Association, 283(10), 1329–1334. doi: 10.1001/jama.283.10.1329
   PubMed Web of Science ®Google Scholar
• Gisslén, M., Price, R. W., & Nilsson, S. (2011). The definition of HIV-associated neurocognitive disorders: Are we overestimating the real prevalence? BMC Infectious Diseases, 11, 356. doi: 10.1186/1471-2334-11-356
   PubMed Web of Science ®Google Scholar
• Grant, I. (2008). Neurocognitive disturbances in HIV. International Review of Psychiatry, 20(1), 33–47. doi: 10.1080/09540260701877894
   PubMed Web of Science ®Google Scholar
• Heaton, R. K., Clifford, D. B., Franklin, D. R. Jr., Woods, S. P., Ake, C., Vaida, F., … Ellis, R. J. (2010). CHARTER Group. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75(23), 2087–2096. doi: 10.1212/WNL.0b013e318200d727
   PubMed Web of Science ®Google Scholar
• Heaton, R., Marcotte, T., Mindt, M. R., Sadek, J., Moore, D. J., Bentley, D. J., … McCutchan, J. A. (2004). The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of International Neuropyschology Society, 10, 317–331.
   PubMed Web of Science ®Google Scholar
• Kelly, J. D., Hartman, C., Graham, J., Kallen, M. A., & Giordano, T. P. (2014). Social support as a predictor of early diagnosis, linkage, retention and adherence to HIV care: Results from the steps study. The Journal of The Association of Nurses in AIDS Care, 25(5), 405–413. doi: 10.1016/j.jana.2013.12.002
   PubMed Web of Science ®Google Scholar
• Lima, V. D., Harrigan, R., Murray, M., Moore, D. M., Wood, E., Hogg, R. S., & Montaner, J. S. (2008). Differential impact of adherence on long-term treatment response among naïve HIV-infected individuals. AIDS, 22(17), 2371–2380. doi:10.1097/QAD.0b013e328315cdd3
   PubMed Web of Science ®Google Scholar
• Robertson, K. R., Su, Z., Margolis, D. M., Krambrink, A., Havlir, D. V., Evans, S., & Skiest, D. J. (2010). Neurocognition effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology, 74, 1260–1266. doi: 10.1212/WNL.0b013e3181d9ed09
   PubMed Web of Science ®Google Scholar
• Sacktor, N. C., Wong, M., Nakasujja, N., Skolasky, R. L., Selnes, O. A., Musisi, S., … Robertson, K. (2005). The international HIV dementia scale: A new rapid screening test for HIV dementia. AIDS, 19, 1367–1374.
   PubMed Web of Science ®Google Scholar
• Schaecher, K. L. (2013). The importance of treatment adherence in HIV. The American Journal of Managed Care, 19(Suppl. 12), 231–237.
   Google Scholar
• Schouten, J., Wit, F. W., Stolte, I. G., van der Valk, M., Geerlings, S. E., de Wolf, F., … Prins, M. (2102). Comorbidity and ageing in HIV-1 infection: The AGE HIV Cohort Study. Oral abstract. AIDS 2012: XIX International AIDS Conference: Abstract THAB0205. Presented July 26, 2012.
   Google Scholar
• Skinner, S., Adewale, A. J., DeBlock, L., Gill, M. J., & Power, C. (2009). Neurocognitive screening tools in HIV/AIDS: Comparative performance among patients exposed to antiretroviral therapy. British HIV Association HIV Medicine, 10, 246–252.
   Google Scholar
• The Kirby Institute. (2014). HIV, viral hepatitis and sexually transmissible infections in Australia. Australian Annual Surveillance Report, 2013. The Kirby Institute, University of New South Wales, Sydney, NSW 2052.
   Google Scholar
• Valcour, V. G., Shikuma, C. M., Watters, M. R., & Sacktor, N. C. (2004). Cognitive impairment in older HIV-1-seropositive individuals: Prevalence and potential mechanisms. AIDS, 18(Suppl. 1), 79–86. doi: 10.1097/00002030-200401001-00012
   PubMed Web of Science ®Google Scholar
• Wacharasin, C., & Homchampa, P. (2008). Uncovering a family caregiving model: Insights from research to benefit HIV infected patients, their caregivers, and health professionals. Journal of the Association of Nurses in AIDS Care, 19(5), 385–396. doi: 10.1016/j.jana.2008.04.012
   PubMed Web of Science ®Google Scholar
• Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O'Shaughnessy, M. V., & Montaner, J. S. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350×10(9) cells/L. Annals of Internal Medicine, 139(10), 810–816. doi: 10.7326/0003-4819-139-10-200311180-00008
   PubMed Web of Science ®Google Scholar